AAAAAA

   
Results: 1-8 |
Results: 8
Oral topotecan as single-agent second-line chemotherapy in patients with advanced ovarian cancer
Authors: Clarke-Pearson, DL Van Le, L Iveson, T Whitney, CW Hanjani, P Kristensen, G Malfetano, JH Beckman, RA Ross, GA Lane, SR DeWitte, MH Fields, SZ
Citation: Dl. Clarke-pearson et al., Oral topotecan as single-agent second-line chemotherapy in patients with advanced ovarian cancer, J CL ONCOL, 19(19), 2001, pp. 3967-3975
Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: A randomized trial
Authors: Maxwell, GL Synan, I Dodge, R Carroll, B Clarke-Pearson, DL
Citation: Gl. Maxwell et al., Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: A randomized trial, OBSTET GYN, 98(6), 2001, pp. 989-995
The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma
Authors: Cirisano, FD Robboy, SJ Dodge, RK Bentley, RC Krigman, HR Synan, IS Soper, JT Clarke-Pearson, DL
Citation: Fd. Cirisano et al., The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma, GYNECOL ONC, 77(1), 2000, pp. 55-65
Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgery
Authors: Maxwell, GL Myers, ER Clarke-Pearson, DL
Citation: Gl. Maxwell et al., Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgery, OBSTET GYN, 95(2), 2000, pp. 206-214
Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea asan adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group Study
Authors: Whitney, CW Sause, W Bundy, BN Malfetano, JH Hannigan, EV Fowler, WC Clarke-Pearson, DL Liao, SY
Citation: Cw. Whitney et al., Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea asan adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group Study, J CL ONCOL, 17(5), 1999, pp. 1339-1348
Epidemiologic and surgicopathologic findings of papillary serous and clearcell endometrial cancers when compared to endometrioid carcinoma
Authors: Cirisano, FD Robboy, SJ Dodge, RK Bentley, RC Krigman, HR Synan, IS Soper, JT Clarke-Pearson, DL
Citation: Fd. Cirisano et al., Epidemiologic and surgicopathologic findings of papillary serous and clearcell endometrial cancers when compared to endometrioid carcinoma, GYNECOL ONC, 74(3), 1999, pp. 385-394
Cost-effectiveness of treatment of early stage endometrial cancer
Authors: Ashih, H Gustilo-Ashby, T Myers, ER Andrews, J Clarke-Pearson, DL Berry, D Berchuck, A
Citation: H. Ashih et al., Cost-effectiveness of treatment of early stage endometrial cancer, GYNECOL ONC, 74(2), 1999, pp. 208-216
Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer
Authors: Rose, PG Bundy, BN Watkins, EB Thigpen, JT Deppe, G Maiman, MA Clarke-Pearson, DL Insalaco, S
Citation: Pg. Rose et al., Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer, N ENG J MED, 340(15), 1999, pp. 1144-1153
Risultati: 1-8 |